Yamashita T, Suzuki N, Motoyoshi K, Zhu W, et al. Characteristics of patients with longer treatment period of lenvatinib for unresectable hepatocellular carcinoma: A post-hoc analysis of post-marketing surveillance study in Japan. PLoS One 2024;19:e0298420.
PMID: 38457389